Innovative
Therapeutics for
Better Health

Because Life
Shouldn't Have to
Wait for Migraines

Our Lead Product Candidate

STS101

Dihydroergotamine (DHE) Nasal Powder

Learn More

Clinical Trials

SUMMIT™ Trial

Currently Recruiting

Learn More

Clinical Trials

ASCEND™ Trial

Ongoing

Learn More

Press Releases

May 11, 2022

Satsuma Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Read More

May 10, 2022

Satsuma Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights

Read More